Preview

谢切诺夫学报

高级搜索

孕早期孕妇生殖因素对产前筛查指标的影响

https://doi.org/10.47093/2218-7332.2020.11.3.37-46

摘要

简介
孕妇生殖因素对孕妇产前筛查中染色体异常(CA),子痫前症(PE),小于胎龄儿(SGA fetus),以及早产(PB)的风险指标的影响尚未得到充分研究。
目的
研究孕妇生殖因素对产前筛查中使用的Astraia Obstetrics 模板评估的染色体异常(CA),子痫前症(PE),小于胎龄儿(SGA fetus),以及早产(PB)风险指标的影响。
材料和方法
在接受产前筛查的11841名孕妇中,有18.53%的患者的检查结果为高风险(频率在1:100甚至更高)。将高风险的患者单独分为几个组,染色体异常-69例,子痫前症(PE)-66例,小于胎龄儿(SGA fetus)-48例,早产-52例。通过按年龄分层随机分组的方式从低危患者组中选择208名进行对照。
结果
在生殖器外疾病中,所有高危组常见为:高血压(AH)I和II级-31–47%,对照组为4.8%(p <0.05),下肢静脉曲张(VVLE)-17-30%,对照组为5.3%(p<0.05),有卵巢肿瘤病史-12-33%,对照组为3%(p<0.05)。在发生染色体异常(CA),子痫前症(PE),小于胎龄儿(SGA fetus)的高危组中,子宫肌瘤和缺铁性贫血相较对照组更常见,分别为:10-41%,对照组为1%(p<0.05),和10-17%,对照组为3%(p<0.05)。有妊娠史的初产妇在染色体异常(CA)(33%)和早产(35%)的高风险组更常见,对照组为17%(p<0.05)。
结论
将所有研究结果与动脉高血压,下肢静脉曲张,卵巢肿瘤病史之间建立关联。与对照组相比,在染色体异常(CA),子痫前症(PE),小于胎龄儿(SGA fetus)的高危亚组中,子宫肌瘤和缺铁性贫血(IDA)的发生率更高。

关于作者

P. M. Samchuk
Sechenov First Moscow State Medical University (Sechenov University); Moscow State Clinical Hospital named after V.V. Veresaev
俄罗斯联邦


A. I. Ishchenko
Sechenov First Moscow State Medical University (Sechenov University)
俄罗斯联邦


E. L. Azoeva
Moscow State Clinical Hospital named after V.V. Veresaev


参考

1. Livrinova V., Petrov I., Samardziski I., et al. Clinical importance of low level of PAPP-a in first trimester of pregnancy — an obstetrical dilemma in chromomally normal fetus. 2019; 7(9): 1475–79. https://doi.org/10.3889/oamjms.2019.384 PMID: 31198458

2. Акушерство: Национальное руководство. Под ред. Г.М. Савельевой, Г.Т. Сухих, В.Н. Серова, В.Е. Радзинского. М.: ГЭОТАР-Медиа. 2019; 1080.

3. Радзинский В. Е. Акушерская агрессия, v. 2.0. М.: Издательство журнала StatusPraesens. 2017; 872.

4. Usta I.M., Zoorob D., Abu-Musa A., et al. Obstetric outcome of teenage pregnancies compared with adult pregnancies. 2008; 87(2): 178–83. https://doi.org/10.1080/00016340701803282 PMID: 18231885

5. Ciancimino L., Laganà A.S., Chiofalo B., et al. Would it be too late? A retrospective case-control analysis to evaluate maternalfetal outcomes in advanced maternal age. 2014; 290(6): 1109–14. https://doi.org/10.1007/s00404-014-3367-5 PMID: 25027820

6. Langley S. A Nutrition Screening Form for Female Infertility Patients. 2014; 75(4): 195–201. https://doi.org/10.3148/cjdpr-2014-024 PMID: 26067073

7. Диагностика и лечение сердечно-сосудистых заболеваний при беременности 2018. Национальные рекомендации. Российский кардиологический журнал. 2018; 3(155): 91–134. http://dx.doi.org/10.15829/1560-4071-2018-3-91-134

8. Стуклов Н.И. Железодефицитная анемия в практике гинеколога. Алгоритмы диагностики, профилактики и лечения. Акушерство и гинекология. 2016; 7: 99–104. http://doi.org/10.18565/aig.2016.7.99-104

9. Farkash E., Weintraub A.Y., Sergienko R., et al. Acute antepartum pyelonephritis in pregnancy: a critical analysis of risk factors and outcomes. Eur J Obstet Gynecol Reprod Biol. 2012; 162(1): 24–7. https://doi.org/10.1016/j.ejogrb.2012.01.024 PMID: 22381037

10. Matuszkiewicz-Rowińska J., Małyszko J., Wieliczko M. Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems. Arch Med Sci. 2015; 11(1): 67–77. https://doi.org/10.5114/aoms.2013.39202 PMID: 25861291

11. Mason E., Chandra-Mouli V., Baltag V., et al. Preconception care: advancing from ‘important to do and can be done’ to ‘is being done and is making a difference’. Reproductive health. 2014; 11 (Suppl 3): S8. https://doi.org/10.1186/1742-4755-11-S3-S8 PMID: 25415261

12. Dean S.V., Imam A.M., Lassi Z.S., Bhutta Z.A. Importance of intervening in the preconception period to impact pregnancy outcomes. 2013; 74: 63–73. https://doi.org/10.1159/000348402 PMID: 23887104

13. Dean S.V., Lassi Z.S., Imam A.M., Bhutta Z.A. Preconception care: closing the gap in the continuum of care to accelerate improvements in maternal, newborn and child health. Reprod Health. 2014; 11(Suppl 3): S1. https://doi.org/10.1186/1742-4755-11-S3- S1 PMID: 25414942

14. Тихомиров А.Л., Сарсания С.И. Проблема железодефицитной анемии у женщин: пути решения. РМЖ. Мать и дитя. 2020; 1: 44–50. https://doi.org/10.32364/2618-8430-2020-3-1-44-50

15. O’Gorman N., Wright D., Poon L.C., et al. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation. Ultrasound Obstet Gynecol. 2017 Jun; 49(6): 751–5. https://doi.org/10.1002/uog.17399 PMID: 28067011

16. Panaitescu A.M., Baschat A.A., Akolekar R., et al. Association of chronic hypertension with birth of small-for-gestational-age neonate. Ultrasound Obstet Gynecol. 2017 Sep; 50(3): 361–6. https://doi.org/10.1002/uog.17553 PMID: 28636133

17. Panaitescu A. M., Syngelaki A., Prodan N., et al. Chronic hypertension and adverse pregnancy outcome: a cohort study. Ultrasound Obstet Gynecol. 2017 Aug; 50(2): 228–35. https://doi.org/10.1002/uog.17493 PMID: 28436175

18. Безнощенко Г.Б., Кравченко Е.Н., Цуканов Ю.Т. и др. Варикозная болезнь у беременных: особенности гестационного периода, флебогемодинамика малого таза и нижних конечностей. Российский вестник акушера-гинеколога. 2016; 16(3): 4–8. https://doi.org/10.17116/rosakush20161634-8

19. Cordina M., Marianna S., Fernandez M., et al. Maternal hemoglobin at 27-29 weeks’ gestation and severity of pre-eclampsia. J Matern Fetal Neonatal Med. 2015 Sep; 28(13): 1575–80. https://doi.org/10.3109/14767058.2014.961006 PMID: 25184521


评论

浏览: 9633


ISSN 2218-7332 (Print)
ISSN 2658-3348 (Online)